PROBLEM TO BE SOLVED: To provide bispecific binding molecules specifically binding to CD3 and a surface target antigen on cancer cells.SOLUTION: The present invention provides a bispecific binding molecule characterized by containing (a) an antibody specifically binding to CD3, and(b) a Fyn-SH3-derived polypeptide binding to a surface target antigen on cancer cells, the Fyn-SH3-derived polypeptide consisting of a specific 63 amino acid sequence, which has at least one substituted, deleted, or added amino acid within amino acid positions 10 to 19, and has at least one substituted, deleted, or added amino acid within positions 29 to 36, and further having at least 85% sequence identity to a sequence consisting of a specific 63 amino acid sequence, the amino acid positions 12 to 17 and 31 to 34 being excluded in identity determination.SELECTED DRAWING: NoneCOPYRIGHT: (C)2019,JPO&INPIT【課題】CD3と、癌細胞上の表面標的抗原と、に特異的に結合する二重特異的結合分子の提供。【解決手段】(a)CD3に特異的に結合する抗体と(b)癌細胞上の表面標的抗原に結合するFyn-SH3由来ポリペプチドとを含み、Fyn-SH3由来ポリペプチドは特定の63アミノ酸配列からなり、アミノ酸位置10~19内の少なくとも1つのアミノ酸は置換、欠失、又は付加されていること、かつ29~36内の少なくとも1つのアミノ酸は、置換、欠失、又は付加されており、さらに特定の63アミノ酸配列からなる配列に対して少なくとも85%の配列同一性を有し、同一性の決定では、アミノ酸位置12~17および31~34が除外されること、を特徴とする二重特異的結合分子の提供。【選択図】なし